Works matching IS 22969403 AND DT 2018 AND VI 2 AND IP 3
Results: 7
Front & Back Matter.
- Published in:
- Inflammatory Intestinal Diseases, 2018, v. 2, n. 3, p. 1, doi. 10.1159/000488562
- Publication type:
- Article
Phospholipase A<sub>2</sub> of Microbiota as Pathogenetic Determinant to Induce Inflammatory States in Ulcerative Colitis: Therapeutic Implications of Phospholipase A<sub>2</sub> Inhibitors.
- Published in:
- Inflammatory Intestinal Diseases, 2018, v. 2, n. 3, p. 180, doi. 10.1159/000486858
- By:
- Publication type:
- Article
Asians Have More Perianal Crohn Disease and Ocular Manifestations Compared with White Americans.
- Published in:
- Inflammatory Intestinal Diseases, 2018, v. 2, n. 3, p. 147, doi. 10.1159/000484347
- By:
- Publication type:
- Article
Efficacy and Safety of Oral Budesonide in Patients with Active Crohn's Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study.
- Published in:
- Inflammatory Intestinal Diseases, 2018, v. 2, n. 3, p. 154, doi. 10.1159/000484047
- By:
- Publication type:
- Article
Cyclophosphamide Pulse Therapy in Severe Refractory Crohn's Disease: A Retrospective Multicenter Case Series.
- Published in:
- Inflammatory Intestinal Diseases, 2018, v. 2, n. 3, p. 139, doi. 10.1159/000481820
- By:
- Publication type:
- Article
Low Discontinuation Rate of Infliximab Treatment in Steroid-Dependent/Refractory Crohn’s Disease Patients.
- Published in:
- Inflammatory Intestinal Diseases, 2018, v. 2, n. 3, p. 171, doi. 10.1159/000486676
- By:
- Publication type:
- Article
Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS).
- Published in:
- Inflammatory Intestinal Diseases, 2018, v. 2, n. 3, p. 163, doi. 10.1159/000486131
- By:
- Publication type:
- Article